SCHEMBL17529322

SCHEMBL17529322

CCC=CCCC#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9968797 1.00
SCHEMBL17532630 0.97 ALDH1A1 (0.42)
SCHEMBL21433096 0.97 ALDH1A1 (0.42)
SCHEMBL21433095 0.97 ALDH1A1 (0.42)
SCHEMBL17511103 0.97 ALDH1A1 (0.42)
SCHEMBL17511074 0.97 ALDH1A1 (0.42)
SCHEMBL17511075 0.97 ALDH1A1 (0.42)
SCHEMBL17511068 0.93 TSHR (0.40)
SCHEMBL21433098 0.93 TSHR (0.40)
SCHEMBL21433097 0.93 TSHR (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114874209-A Oxadiazole transient receptor potential channel inhibitors 豪夫迈·罗氏有限公司 2022-08-09 CN disclosed
CN-110461838-B Oxadiazole transient receptor potential channel inhibitors 豪夫迈·罗氏有限公司 2022-05-06 CN disclosed
EP-3768668-A1 SHP2 PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF Relay Therapeutics, Inc. (US) 2021-01-27 EP disclosed
WO-2019183367-A1 SHP2 PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. (US) 2019-09-26 WO disclosed
WO-2016028892-A1 PERFUME COMPOSITIONS CONTAINING ISOMERIC ALKADIENALS BEDOUKIAN RESEARCH, INC. (US) 2016-02-25 WO disclosed